American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
The American Gastroenterological Association (AGA) convened a panel of gastroenterologists expert in the area of inflammatory bowel disease (IBD) that developed this consensus statement based on expert presentations of current scientific knowledge about IBD and through subsequent group discussion. T...
Main Authors: | Clark, M, Colombel, J, Feagan, B, Fedorak, R, Hanauer, S, Kamm, M, Mayer, L, Regueiro, C, Rutgeerts, P, Sandborn, W, Sands, B, Schreiber, S, Targan, S, Travis, S, Vermeire, S |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2007
|
Títulos similares
-
Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
por: Gottlieb, K, et al.
Publicado: (2015) -
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
por: D'Haens, G, et al.
Publicado: (2009) -
The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy.
por: Travis, S, et al.
Publicado: (2012) -
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
por: D'Haens, G, et al.
Publicado: (2011) -
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.
por: Silverberg, MS, et al.
Publicado: (2005)